-200x200.jpg "Telmidip 5/40 tab")
-200x200.jpg "accu-check instant 25 strip")
-200x200.jpg "Raditil 20 mg")
-200x200.jpg "Ice Bag")
-200x200.jpg "First Aid box(medium)")
-200x200.jpg "Exercise Mat/Yoga Mat (Good Quality)")
-200x200.jpg "Dibedex 500mg cap 1 strip")
Ace 125 Suppository
Indication: Fever, headache, toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains. Colic pain, back pain, chronic pain of cancer, inflammatory pain, and post-vaccination pain and fever of children. Rheumatism and osteoarthritic pain & stiffness of joints in fingers, hips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.Dosage & Administration:Tablet: Adults 1-2 tablets every 4 to 6 hours up to a maximum of 4g (8 tablets) daily. Children (6-12 years) 1/2 to 1 tablet 3 to 4 times daily. Syrup and Suspension: Children (3 months to below 1 year) 1/2 to 1 teaspoonful 3 to 4 times daily. Children (1-5 years) 1-2 teaspoonful 3 to 4 times daily. Children (6-12 years) 2-4 teaspoonful 3 to 4 times daily. Adults: 4-8 teaspoonful 3 to 4 times daily. Paediatric Drops: Children (0-3 months): 0.5 ml. Children (4 to 11 months) 1.0 ml. Children (1 to 2 years) 1.5 ml. Dose can be repeated, every 4 hours. Suppository: Suppository should be administered rectaly. Children (3 months - 1 year) 60-120 mg 4 times daily.Show more Preparation: Ace® Tablet: Each box contains 500 tablets in blister pack. Ace® XR Tablet: Each box contains 100 tablets in blister pack. Ace® Syrup (60 ml): 60 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Syrup (100 ml): 100 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Suspension: 60 ml suspension in sealed cap PET bottle. Ace® Paediatric drops (30 ml): 30 ml paediatric drop in sealed cap PET bottle (with dropper). Ace® 125 Suppository: Each box contains 20 suppositories in blister pack. Ace® 250 Suppository: Each box contains 20 suppositories in blister pack. Ace® 500 Suppository: Each box contains 20 suppositories in blister pack. ..
Tk.4.00/=
Ace 250 Suppository
Indication: Fever, headache, toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains. Colic pain, back pain, chronic pain of cancer, inflammatory pain, and post-vaccination pain and fever of children. Rheumatism and osteoarthritic pain & stiffness of joints in fingers, hips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.Dosage & Administration:Tablet: Adults 1-2 tablets every 4 to 6 hours up to a maximum of 4g (8 tablets) daily. Children (6-12 years) 1/2 to 1 tablet 3 to 4 times daily. Syrup and Suspension: Children (3 months to below 1 year) 1/2 to 1 teaspoonful 3 to 4 times daily. Children (1-5 years) 1-2 teaspoonful 3 to 4 times daily. Children (6-12 years) 2-4 teaspoonful 3 to 4 times daily. Adults: 4-8 teaspoonful 3 to 4 times daily. Paediatric Drops: Children (0-3 months): 0.5 ml. Children (4 to 11 months) 1.0 ml. Children (1 to 2 years) 1.5 ml. Dose can be repeated, every 4 hours. Suppository: Suppository should be administered rectaly. Children (3 months - 1 year) 60-120 mg 4 times daily.Show more Preparation: Ace® Tablet: Each box contains 500 tablets in blister pack. Ace® XR Tablet: Each box contains 100 tablets in blister pack. Ace® Syrup (60 ml): 60 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Syrup (100 ml): 100 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Suspension: 60 ml suspension in sealed cap PET bottle. Ace® Paediatric drops (30 ml): 30 ml paediatric drop in sealed cap PET bottle (with dropper). Ace® 125 Suppository: Each box contains 20 suppositories in blister pack. Ace® 250 Suppository: Each box contains 20 suppositories in blister pack. Ace® 500 Suppository: Each box contains 20 suppositories in blister pack. ..
Tk.5.00/=
Ace 500 Suppository
Indication: Fever, headache, toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains. Colic pain, back pain, chronic pain of cancer, inflammatory pain, and post-vaccination pain and fever of children. Rheumatism and osteoarthritic pain & stiffness of joints in fingers, hips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.Dosage & Administration:Tablet: Adults 1-2 tablets every 4 to 6 hours up to a maximum of 4g (8 tablets) daily. Children (6-12 years) 1/2 to 1 tablet 3 to 4 times daily. Syrup and Suspension: Children (3 months to below 1 year) 1/2 to 1 teaspoonful 3 to 4 times daily. Children (1-5 years) 1-2 teaspoonful 3 to 4 times daily. Children (6-12 years) 2-4 teaspoonful 3 to 4 times daily. Adults: 4-8 teaspoonful 3 to 4 times daily. Paediatric Drops: Children (0-3 months): 0.5 ml. Children (4 to 11 months) 1.0 ml. Children (1 to 2 years) 1.5 ml. Dose can be repeated, every 4 hours. Suppository: Suppository should be administered rectaly. Children (3 months - 1 year) 60-120 mg 4 times daily.Show more Preparation: Ace® Tablet: Each box contains 500 tablets in blister pack. Ace® XR Tablet: Each box contains 100 tablets in blister pack. Ace® Syrup (60 ml): 60 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Syrup (100 ml): 100 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Suspension: 60 ml suspension in sealed cap PET bottle. Ace® Paediatric drops (30 ml): 30 ml paediatric drop in sealed cap PET bottle (with dropper). Ace® 125 Suppository: Each box contains 20 suppositories in blister pack. Ace® 250 Suppository: Each box contains 20 suppositories in blister pack. Ace® 500 Suppository: Each box contains 20 suppositories in blister pack. ..
Tk.8.06/=
Ace 500 mg Tablet
Indication: Fever, headache, toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains. Colic pain, back pain, chronic pain of cancer, inflammatory pain, and post-vaccination pain and fever of children. Rheumatism and osteoarthritic pain & stiffness of joints in fingers, hips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.Dosage & Administration:Tablet: Adults 1-2 tablets every 4 to 6 hours up to a maximum of 4g (8 tablets) daily. Children (6-12 years) 1/2 to 1 tablet 3 to 4 times daily. Syrup and Suspension: Children (3 months to below 1 year) 1/2 to 1 teaspoonful 3 to 4 times daily. Children (1-5 years) 1-2 teaspoonful 3 to 4 times daily. Children (6-12 years) 2-4 teaspoonful 3 to 4 times daily. Adults: 4-8 teaspoonful 3 to 4 times daily. Paediatric Drops: Children (0-3 months): 0.5 ml. Children (4 to 11 months) 1.0 ml. Children (1 to 2 years) 1.5 ml. Dose can be repeated, every 4 hours. Suppository: Suppository should be administered rectaly. Children (3 months - 1 year) 60-120 mg 4 times daily.Show more Preparation: Ace® Tablet: Each box contains 500 tablets in blister pack. Ace® XR Tablet: Each box contains 100 tablets in blister pack. Ace® Syrup (60 ml): 60 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Syrup (100 ml): 100 ml syrup in sealed cap PET bottle (with measuring cup). Ace®Suspension: 60 ml suspension in sealed cap PET bottle. Ace® Paediatric drops (30 ml): 30 ml paediatric drop in sealed cap PET bottle (with dropper). Ace® 125 Suppository: Each box contains 20 suppositories in blister pack. Ace® 250 Suppository: Each box contains 20 suppositories in blister pack. Ace® 500 Suppository: Each box contains 20 suppositories in blister pack...
Tk.1.20/=
Ace Plus Tablet
Indication: Fever, headache, migraine, muscle ache, backache, toothache & menstrual pain.Dosage & Administration:Adults: 1-2 tablets every 4-6 hours. Maximum dose: 8 tablets daily. Not recommended for children below 12 years.Preparation: Each box contains 200 tablets of Paracetamol 500 mg & Caffeine 65 mg in a blister pack...
Tk.2.51/=
Ace XR Tablet
Indication: Fever, headache, toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains. Colic pain, back pain, chronic pain of cancer, inflammatory pain, and post-vaccination pain and fever of children. Rheumatism and osteoarthritic pain & stiffness of joints in fingers, hips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.Dosage & Administration:Tablet: Adults 1-2 tablets every 4 to 6 hours up to a maximum of 4g (8 tablets) daily. Children (6-12 years) 1/2 to 1 tablet 3 to 4 times daily. Syrup and Suspension: Children (3 months to below 1 year) 1/2 to 1 teaspoonful 3 to 4 times daily. Children (1-5 years) 1-2 teaspoonful 3 to 4 times daily. Children (6-12 years) 2-4 teaspoonful 3 to 4 times daily. Adults: 4-8 teaspoonful 3 to 4 times daily. Paediatric Drops: Children (0-3 months): 0.5 ml. Children (4 to 11 months) 1.0 ml. Children (1 to 2 years) 1.5 ml. Dose can be repeated, every 4 hours. Suppository: Suppository should be administered rectaly. Children (3 months - 1 year) 60-120 mg 4 times daily.Show more Preparation: Ace® Tablet: Each box contains 500 tablets in blister pack. Ace® XR Tablet: Each box contains 100 tablets in blister pack. Ace® Syrup (60 ml): 60 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Syrup (100 ml): 100 ml syrup in sealed cap PET bottle (with measuring cup). Ace® Suspension: 60 ml suspension in sealed cap PET bottle. Ace® Paediatric drops (30 ml): 30 ml paediatric drop in sealed cap PET bottle (with dropper). Ace® 125 Suppository: Each box contains 20 suppositories in blister pack. Ace® 250 Suppository: Each box contains 20 suppositories in blister pack. Ace® 500 Suppository: Each box contains 20 suppositories in blister pack. 123456789 ..
Tk.1.51/=
Acetram Tab
Indication: Management of moderate to moderately sever pain in adults & also indicated for the short-term (five days or less) management of acute. Dosage & Administration:Acetram tablet can be administered without regard to food. For the management of pain, the recommended dose is 1 or 2 tablets every 4 to 6 hours as needed for pain relief up to a maximum of 8 tablets per day. In case of short-term (five days or less) management of acute pain, the recommended dose is 2 tablets every 4 to 6 hours as needed for pain relief up to maximum of 8 tablets per day. Preparation: Each box contains 30 tablets of Paracetamol 325 mg & Tramadol Hydrochloride 37.5 mg in a blister pack. ..
Tk.8.03/=
Adovas 100 ml Syrup
Adovas Syp 100 ml Indication:Adovas® is a sugar free, non sedating herbal cough syrup. It liquefies phlegm. It is effective for all kinds of common cold and cough such as, dry irritable cough, allergic cough, smokers cough and cough associated with bronchitis. It soothens the throat irritation and relieves hoarseness.Dosage & Administration:Adults: 3 tea spoonfuls (15 ml) 2-3 times a day. In acute cough warm water can be added for better result.Children under 12 years of age: 1-2 teaspoonful (5-10 ml) 3 times a day.Preparation:100 ml & 200ml Syrup in PET bottle...
Tk.70.00/=
Adovas 200 ml Syrup
Adovas Syp 200 ml Indication:Adovas® is a sugar free, non sedating herbal cough syrup. It liquefies phlegm. It is effective for all kinds of common cold and cough such as, dry irritable cough, allergic cough, smokers cough and cough associated with bronchitis. It soothens the throat irritation and relieves hoarseness.Dosage & Administration:Adults: 3 tea spoonfuls (15 ml) 2-3 times a day. In acute cough warm water can be added for better result.Children under 12 years of age: 1-2 teaspoonful (5-10 ml) 3 times a day.Preparation:100 ml & 200ml Syrup in PET bottle...
Tk.110.00/=
Alacot 0.1% Ophthalmic Solution
Alacot 0.1% Ophthalmic SolutionIndication:Indicated for the treatment of the signs and symptoms of allergic conjunctivitis.Dosage & Administration:One drop in each affected eye two times per day at an interval of 6 to 8 hours.Preparation:0.1% Eye Drops...
Tk.110.34/=
Alarid Tablet 1 mg
Alarid Tablet 1 mg Indication:• Prophylactic treatment of bronchial asthma• Symptomatic treatment of allergic conditions including rhinitis and conjunctivitisDosage & Administration:Adults: 1 mg twice daily with food. If necessary, the dose may be increased to 2 mg twice daily in severe cases.Children above 3 years: 1 mg twice daily with food. Patients known to be easily sedated should begin treatment with 0.5 to 1 mg at night for the first few days or as directed by the physician.Use in elderly: Same as adult dose or as advised by the physician.Preparation:Alarid® Tablet: Each box contains 100’s tablets in blister pack.Alarid® Syrup: Each PET bottle contains 100 ml syrup and a measuring cup...
Tk.2.50/=
Alatrol 10mg tab
Indication: Alatrol® is indicated for the relief of symptoms associated with seasonal allergic rhinitis due to allergen. Symptoms treated effectively include sneezing, rhinorrhea, pruritus, ocular pruritus, tearing and redness of the eyes. Alatrol® is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens. Symptoms treated effectively include sneezing, rhinorrhea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing. Alatrol® is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria. It is also used in allergen induced asthma.Dosage & Administration:Alatrol® is administered with or without food. Adults and Children 6 years and older: ..
Tk.3.01/=
Alatrol 60ml Syp
Indication: Alatrol® is indicated for the relief of symptoms associated with seasonal allergic rhinitis due to allergen. Symptoms treated effectively include sneezing, rhinorrhea, pruritus, ocular pruritus, tearing and redness of the eyes. Alatrol® is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens. Symptoms treated effectively include sneezing, rhinorrhea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing. Alatrol® is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria. It is also used in allergen induced asthma.Dosage & Administration:Alatrol® is administered with or without food. Adults and Children 6 years and older: ..
Tk.30.10/=
Almex 400 mg Tablet
Indication: Single or mixed intestinal infections caused by various helminths.Dosage & Administration:12 to 24 months: 200 mg as a single dose (Half of Almex® 400 tablet or 5 ml Almex® suspension). Adults & children (over 2 years): Ascariasis, enterobiasis, trichuriasis & hookworm infestation - 400 mg (One Almex® 400 tablet or 10 ml Almex® suspension) single dose. Strogyloidiasis or taeniasis - 400 mg once daily for three consecutive days. Giardiasis - 400 mg once daily for five days. Hydatid disease (Echinococcosis)-400 mg twice daily for 28 days. For cystic echinococcosis the 28-days course may be repeated after 14 days without treatment to a total of three treatment cycles. For alveolar echinococcosis, 400 mg twice daily for 28 days followed by 14 days wShow more Preparation: Almex® 400 Tablet: Each box contains 12×4’s tablets in blister pack. ..
Tk.5.02/=
Ambrox 100ml Syrup
Ambrox SyrupIndicationsAcute and chronic diseases of respiratory tracts associated with viscid mucus including acute and chronic bronchitisProductive coughInflammatory diseases of Rhinopharyngeal tract (e.g. Laryngitis, Pharyngitis, Sinusitis and Rhinitis) associated with viscid mucusAsthmatic bronchitis, Bronchial asthma with difficult departure of mucusBronchiectasisChronic pneumonia.Therapeutic ClassCough expectorants & mucolyticsPharmacologyAmbroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency. Beside these, Ambroxol also exhibits anti oxidant activity. Long-term use is possible because of the good tolerability of the preparation.Dosage & AdministrationAverage daily dose (preferably after meal):Syrup:2-5 years: 2.5 ml (1/2 teaspoonful) 2-3 times a day5-10 years: 5 ml (1 teaspoonful) 2-3 times a day10 years and adults: 10 ml (2 teaspoonful) 3 times a day.Sustained release capsule:Adult and children over 12 years old: 1 capsule once dailySpecific application features: Ambroxol may be prescribed to patients suffering from diabetes mellitus.InteractionAmbroxol has no interaction with cardioactive glycosides, corticosteroids, bronchodilators, diuretics and antibiotics (normally used in the treatment of bronchopulmonary affections). But Ambroxol should not be taken simultaneously with antitussives (e.g. Codeine) because mucus, which has been liquefied by Ambroxol, might not be expectorated.ContraindicationsContraindicated in known hypersensitivity to Ambroxol or Bromhexine.Side EffectsGastrointestinal side-effects like epigastric pain, gastric fullness may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema may occur...
Tk.50.00/=
Ambrox 15ml Pediatric Drops
Ambrox 15ml Pediatric DropsIndicationsAcute and chronic diseases of respiratory tracts associated with viscid mucus including acute and chronic bronchitisProductive coughInflammatory diseases of Rhinopharyngeal tract (e.g. Laryngitis, Pharyngitis, Sinusitis and Rhinitis) associated with viscid mucusAsthmatic bronchitis, Bronchial asthma with difficult departure of mucusBronchiectasisChronic pneumonia.Therapeutic ClassCough expectorants & mucolyticsPharmacologyAmbroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency. Beside these, Ambroxol also exhibits anti oxidant activity. Long-term use is possible because of the good tolerability of the preparation.Dosage & AdministrationAverage daily dose (preferably after meal):Pediatric Drops:0-6 months: 0.5 ml 2 times a day6-12 months: 1 ml 2 times a day1-2 years: 1.25 ml 2 times a dayAdult and children over 12 years old: 1 capsule once dailySpecific application features: Ambroxol may be prescribed to patients suffering from diabetes mellitus.InteractionAmbroxol has no interaction with cardioactive glycosides, corticosteroids, bronchodilators, diuretics and antibiotics (normally used in the treatment of bronchopulmonary affections). But Ambroxol should not be taken simultaneously with antitussives (e.g. Codeine) because mucus, which has been liquefied by Ambroxol, might not be expectorated.ContraindicationsContraindicated in known hypersensitivity to Ambroxol or Bromhexine.Side EffectsGastrointestinal side-effects like epigastric pain, gastric fullness may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema may occur...
Tk.35.00/=
Amodis 500 IV
Indication: Amodis® 500 IV is indicated in the prophylaxis and treatment of infections in which anaerobic bacteria have been identified. It is indicated in- 1. The prevention of postoperative infections due to anaerobic bacteria 2. The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, necrotizing pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, and post operative wound infections from which pathogenic anaerobes have been isolated.Dosage & Administration:Amodis® 500 IV should be infused intravenously at an approximate rate of 5 ml/min. Oral medication should be substituted as soon as feasible. Treatment for 7 days should be satisfactory for most patients, but the physician might decide to prolong treatment. For bacterial infections: Adults: 500 mg (100 ml) 8 hourly. Children: 7.5 mg/kg (1.5 ml/kg) 8 hourly. For treatment before and during surgery: Adults: 500 mg (100 ml) shortly before operation, repeated 8 hourly. Children: 7.5 mg/kg (1.5 ml/kg) 8 hourly.Preparation: Amodis® 500 IV: Each box contains 1 bottle of 100 ml solution of Metronidazole (500 mg) for intravenous infusion. ..
Tk.53.56/=
Amodis 500 Tab
Indication: All forms of amoebiasis (intestinal and extra-intestinal disease including liver abscess and that of symptomless cyst passers) Trichomoniasis Giardiasis Bacterial vaginosis Acute ulcerative gingivitis Anaerobic infections including septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis etc. Anaerobically-infected leg ulcers and pressure sores Acute dental infections (e.g. acute pericoronitis and acute apical infections) Surgical prophylaxis (prevention of postoperative infections due to anaerobic bacteria, particularly species of bacteroides and anaerobic streptococci Chronic symptomatic peptic ulcer disease (as an agent)Dosage & Administration:For detail please see the full prescribing informationPreparation: Amodis® 400 Tablet: Each box contains 20 x 10 tablets. Amodis® 500 Tablet: Each box contains 10 x 10 tablets. Amodis® 60 Suspension: 60 ml Syrup in PET bottle. ..
Tk.1.91/=
Amodis 60 ml suspension
Indication: All forms of amoebiasis (intestinal and extra-intestinal disease including liver abscess and that of symptomless cyst passers) Trichomoniasis Giardiasis Bacterial vaginosis Acute ulcerative gingivitis Anaerobic infections including septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis etc. Anaerobically-infected leg ulcers and pressure sores Acute dental infections (e.g. acute pericoronitis and acute apical infections) Surgical prophylaxis (prevention of postoperative infections due to anaerobic bacteria, particularly species of bacteroides and anaerobic streptococci Chronic symptomatic peptic ulcer disease (as an agent)Dosage & Administration:For detail please see the full prescribing informationAmodis® 60 Suspension: 60 ml Syrup in PET bottle...
Tk.29.79/=
Anadol 100 Inj
Indication: Anadol® (Tramadol) is used for the treatment of moderate to severe painful conditions. These include: Postoperative pain, Colic and spastic pain, Cancer pain, Joint pain, Neck and back pain & Pain associated with osteoporosis.Dosage & Administration:Anadol® Capsule: Usual doses are 50 to 100 mg every four to six hours. For acute pain an initial dose of 100 mg is required. For chronic painful conditions an initial dose of 50 mg is recommended. Subsequent doses should be 50 to 100 mg administered 4-6 hourly. The dose level and frequency of dosing will depend on the severity of the pain. The total daily dosage by mouth should not exceed 400 mg.Preparation: Each box contains 40 capsules Tramadol HCL 50 mg in a blister pack. Each box contains 30 SR capsule of Tramadol HCL 100 mg in a blister pack. Each box contains 20 suppositories of Tramadol HCL 100 mg in a blister pack. Each box contains 10 ampoules of Tramadol HCL 100 mg/2ml injection in a blister pack. ..
Tk.20.14/=
Anadol 100 SR Cap
Indication: Anadol® (Tramadol) is used for the treatment of moderate to severe painful conditions. These include: Postoperative pain, Colic and spastic pain, Cancer pain, Joint pain, Neck and back pain & Pain associated with osteoporosis.Dosage & Administration:Anadol® Capsule: Usual doses are 50 to 100 mg every four to six hours. For acute pain an initial dose of 100 mg is required. For chronic painful conditions an initial dose of 50 mg is recommended. Subsequent doses should be 50 to 100 mg administered 4-6 hourly. The dose level and frequency of dosing will depend on the severity of the pain. The total daily dosage by mouth should not exceed 400 mg.Preparation: Each box contains 40 capsules Tramadol HCL 50 mg in a blister pack. Each box contains 30 SR capsule of Tramadol HCL 100 mg in a blister pack. Each box contains 20 suppositories of Tramadol HCL 100 mg in a blister pack. Each box contains 10 ampoules of Tramadol HCL 100 mg/2ml injection in a blister pack. ..
Tk.12.09/=
Anclog 75 mg Tablet
Indication: Atherosclerotic disease (ischemic stroke, myocardial infarction or established peripheral arterial disease), prophylactically in patients at the risk of thrombo-embolic disorders such as myocardial infarction and stroke. Dosage & Administration:One tablet once daily.Preparation: Anclog® 75 tablet : Each box contains 40 tablets in blister pack. ..
Tk.12.03/=
Anclog PLUS 75mg Tablet
Indication: Prevention of atherosclerotic events in patients with history of symptomatic atherosclerotic diseases (ischemic stroke, myocardial infarction or acute coronary syndrome).Dosage & Administration:Once daily.Preparation: Anclog® Plus tablet-Each box contains 40 tablets in blister pack. ..
Tk.12.30/=
Anespine Inj
Indication: Spinal anesthesia for- . Urological surgery (lasting 2-3 hours) . Lower limb surgery (lasting 2-3 hours) . Abdominal surgery (lasting 45-60 minutes) Dosage & Administration:Spinal anesthesia for surgery: 2-4 ml (10-20 mg Bupivacaine Hydrochloride). The spread of anesthesia obtained with Anespine® depends on several factors including the volume of solution and the position of the patient during and following the injection. When injected in the L3-L4 intervertebral space with the patient in the sitting position, 3 ml of Anespine® spreads to the T7-T10 spinal segments. With the patient receiving the injection in the horizontal position and then turned supine, the blockade spreads to T4-T7 spinal segments. It should be understood that the level of spinal anesthesia achieved with any local anesthetic can be unpredictable in a givenShow more Preparation: Intraspinal injection, each ml containing Bupivacaine HCl USP 5 mg & Dextrose Monohydrate USP 80 mg (each box contains 10 ampoules in blister packaging). ..
Tk.30.20/=
Angilock Plus 100/25 Tablet
Indication: Angilock® Plus is indicated for the treatment of hypertension. It is also indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophyDosage & Administration:The usual starting dose is Angilock® Plus 50/12.5 one tablet once daily. More than two tablets of Angilock® Plus 50/12.5 or one tablet of Angilock® Plus 100/25 once daily is not recommended. Patients whose blood pressure is not adequately controlled with losartan or hydrochlorothiazide monotherapy, may be switched to Angilock® Plus 50/12.5 once daily. If blood pressure remains uncontrolled after about three weeks of therapy, the dose may be increased to one tablet of Angilock® Plus 100/12.5 or two tablets of Angilock® Plus 50/12.5 or one Angilock® Plus 100/25 once daily. Patients whose blood pressure is not adequately controlled with losartan 100 mg monotheShow more Preparation: Angilock® Plus 50/12.5 Tablet: Box containing 50 tablets in Alu-Alu blister pack. Angilock® Plus 100/12.5 Tablet: Box containing 30 tablets in Alu-Alu blister pack. ® Plus 100/25 Tablet: Box containing 30 tablets in Alu-Alu blister pack. ..
Tk.12.03/=
Angilock Plus 50/12.5 Tablet
Indication: Angilock® Plus is indicated for the treatment of hypertension. It is also indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophyDosage & Administration:The usual starting dose is Angilock® Plus 50/12.5 one tablet once daily. More than two tablets of Angilock® Plus 50/12.5 or one tablet of Angilock® Plus 100/25 once daily is not recommended. Patients whose blood pressure is not adequately controlled with losartan or hydrochlorothiazide monotherapy, may be switched to Angilock® Plus 50/12.5 once daily. If blood pressure remains uncontrolled after about three weeks of therapy, the dose may be increased to one tablet of Angilock® Plus 100/12.5 or two tablets of Angilock® Plus 50/12.5 or one Angilock® Plus 100/25 once daily. Patients whose blood pressure is not adequately controlled with losartan 100 mg monotheShow more Preparation: Angilock® Plus 50/12.5 Tablet: Box containing 50 tablets in Alu-Alu blister pack. Angilock® Plus 100/12.5 Tablet: Box containing 30 tablets in Alu-Alu blister pack. ® Plus 100/25 Tablet: Box containing 30 tablets in Alu-Alu blister pack. ..
Tk.8.03/=
Angivent MR Tab
Indication: Long-term treatment of angina pectoris.Dosage & Administration:1 tablet at mealtimes in the morning and evening.Preparation: Angivent® MR tablet: Each box contains 30 tablets in blister pack. ..
Tk.8.00/=
Anleptic susp 100 ml
Indication: Anleptic® is indicated for . partial and secondary generalized tonic-clonic seizures . primary generalized tonic-clonic seizures . trigeminal neuralgia . prophylaxis of bipolar disorder Dosage & Administration:Epilepsy: Adults and children over 12 years of age - Initial: Either 200 mg b.i.d. for tablets and XR tablets, or 1 teaspoon q.i.d. for suspension (400 mg/day). Increase at weekly intervals by adding up to 200 mg/day using a b.i.d or a t.i.d. or q.i.d. regimen of the either formulations until the optimal response is obtained. Dosage generally should not exceed 1000 mg daily in children 12-15 years of age, and 1200 mg daily in patients above 15 years of age. Doses up to 1600 mg daily have been used in adults in rare instances. Maintenance: usually 800-1200 mg daily. Children 6-12 years of age - Initial: Either 100 mg b.i.d. for tablets or XR tablets, or 1/2Show more Preparation: Anleptic ® 200 tablet: Each box contains 50 tablets in blister packs. Anleptic ® 200 CR tablet: Each box contains 50 tablets in blister packs. Anleptic ® suspension: Each bottle contains 100 ml suspension in PET bottle. ..
Tk.300.90/=
Anril SR 2.6 mg Tab
Indication: The prophylaxis of chronic stable angina pectoris.Dosage & Administration:1 or 2 tablets taken three times daily. The lowest effective dose should be used.Preparation: Anril® SR Tablet: Box containing 50 Sustained Realese tablets in Alu-Alu blister pack. ..
Tk.5.00/=
Ansulin 30/70 100IU/ml (10ml) Inj
Indication: Type 1 and Type 2 Diabetes Mellitus. Dosage & Administration The dosage form, the dosage and the administration time of the insulin are different due to the individual differences of each patient. In addition, the dosage is also affected by food, working style and exercising intensity. Therefore, patients should use the insulin under doctor\'s instruction. The average range of total daily insulin requirement for maintenance therapy in type 1 diabetic patients lies between 0.5 and 1.0 IU/kg. In pre-pubertal children it usually varies from 0.7 to 1.0 IU/kg, whereas in insulin resistant cases, e.g. during puberty or due to obesity, the daily insulin requirement may be substantially higher. Initial dosages for type 2 diabetic patients are often lower, e.g. 0.3 to 0.6 IU/kg/day. PHARMACOLOGY Ansulin® is human insulin made by DNA recombinant technology so it has the same structure and function as natural insulin. The product can regulate the glucose metabolism and stimulate the ingestion and utilization of glucose by liver, muscles, and fat tissue. It can accelerate the transformation from glucose to glycogen stored in muscles and liver and inhibit the gluconeogenesis, thus, to lower the blood glucose. Normally, Ansulin® R takes effect within 30 minutes after injection, reaches its peak within 1-3 hours and lasts about 4-8 hours. On the other hand, Ansulin® N comes into effect slowly after injection, reaches its peak within 6-9 hours & lasts about 24 hours. Ansulin® 30/70 & Ansulin® 50/50 take effect within 30 minutes after injection, reach their peaks within 2-8 hours and last about 24 hours. USAGE 1. Ansulin® should be injected subcutaneously 15 minutes to one hour before meal. The exact time for administration is suggested by doctors with regard to each individual's case. 2. Prepare before use Firstly, clean your hands. Shake or rotate the vial gently to mix the solution uniformly and check if the insulin has the normal appearance. If using a new Ansulin® bottle then flip off the plastic protective cap and wipe the rubber stopper with an alcohol swab. Draw air into your syringe equal to the amount of insulin needed. Puncture the needle into the vial and inject the air. Turn the bottle and syringe upside down. Withdraw correct dose of insulin into the syringe. Before pulling out the needle, check if there are any bubbles remain in the syringe. If so, put the syringe upright and tap the syringe to discharge the air bubbles. 3. Injection Site Choose the area where skin is less tight, such as the upper arm, thigh, buttock and abdomen, etc. To avoid tissue damage, choose a site for each injection that is at least 1 cm from the previous injection site. 4. Injection Method Cleanse the skin with alcohol where the injection is to be made. Put the needle in such a position as to form 45° angle with the skin. Puncture the needle into skin and inject insulin. Then pull the needle out and apply gentle pressure over the injected site for several seconds. Do not rub the injection site. DOSAGE The dosage form, the dosage and the administration time of the insulin are different due to the individual differences of each patient. In addition, the dosage is also affected by food, working style and exercising intensity. Therefore, patients should use the insulin under doctor's instruction. The average range of total daily insulin requirement for maintenance therapy in type 1 diabetic patients lies between 0.5 and 1.0 IU/kg. In pre-pubertal children it usually varies from 0.7 to 1.0 IU/kg, whereas in insulin resistant cases, e.g. during puberty or due to obesity, the daily insulin requirement may be substantially higher. Initial dosages for type 2 diabetic patients are often lower, e.g. 0.3 to 0.6 IU/kg/day. ADVERSE EFFECT Hypoglycemia is the most common adverse effect during insulin treatment and symptoms of hypoglycemia may occur suddenly. Few cases of the allergic reaction such as red and swollen or itching are reported. It usually disappears in a few days. In some instances, the allergy may be caused by other reasons rather than insulin, such as disinfectant and poor injection technique. CONTRAINDICATION Hypoglycemia or the patients who have allergic reaction to insulin or any of the excipients. PRECAUTION Inadequate dosing or discontinuation especially in type 1 diabetes, may lead to hyperglycemia. Hypoglycemia may occur if the insulin dose is too high in relation to the insulin requirement. Omission of a meal or unplanned, strenuous physical exercise may lead to hypoglycemia. PREGNANCY AND LACTATION There are no restrictions on treatment of diabetes with insulin during pregnancy, as ..
Tk.415.00/=
Ansulin 30/70 40IU (10ml) Injection
Indication: Type 1 and Type 2 Diabetes Mellitus.Dosage & AdministrationThe dosage form, the dosage and the administration time of the insulin are different due to the individual differences of each patient. In addition, the dosage is also affected by food, working style and exercising intensity. Therefore, patients should use the insulin under doctor\'s instruction. The average range of total daily insulin requirement for maintenance therapy in type 1 diabetic patients lies between 0.5 and 1.0 IU/kg. In pre-pubertal children it usually varies from 0.7 to 1.0 IU/kg, whereas in insulin resistant cases, e.g. during puberty or due to obesity, the daily insulin requirement may be substantially higher. Initial dosages for type 2 diabetic patients are often lower, e.g. 0.3 to 0.6 IU/kg/day.PHARMACOLOGYAnsulin® is human insulin made by DNA recombinant technology so it has the same structure and function as natural insulin. The product can regulate the glucose metabolism and stimulate the ingestion and utilization of glucose by liver, muscles, and fat tissue. It can accelerate the transformation from glucose to glycogen stored in muscles and liver and inhibit the gluconeogenesis, thus, to lower the blood glucose. Normally, Ansulin® R takes effect within 30 minutes after injection, reaches its peak within 1-3 hours and lasts about 4-8 hours. On the other hand, Ansulin® N comes into effect slowly after injection, reaches its peak within 6-9 hours & lasts about 24 hours. Ansulin® 30/70 & Ansulin® 50/50 take effect within 30 minutes after injection, reach their peaks within 2-8 hours and last about 24 hours.USAGE1. Ansulin® should be injected subcutaneously 15 minutes to one hour before meal. The exact time for administration is suggested by doctors with regard to each individual's case.2. Prepare before use Firstly, clean your hands. Shake or rotate the vial gently to mix the solution uniformly and check if the insulin has the normal appearance.If using a new Ansulin® bottle then flip off the plastic protective cap and wipe the rubber stopper with an alcohol swab. Draw air into your syringe equal to the amount of insulin needed. Puncture the needle into the vial and inject the air. Turn the bottle and syringe upside down. Withdraw correct dose of insulin into the syringe. Before pulling out the needle, check if there are any bubbles remain in the syringe. If so, put the syringe upright and tap the syringe to discharge the air bubbles.3. Injection Site Choose the area where skin is less tight, such as the upper arm, thigh, buttock and abdomen, etc. To avoid tissue damage, choose a site for each injection that is at least 1 cm from the previous injection site.4. Injection Method Cleanse the skin with alcohol where the injection is to be made. Put the needle in such a position as to form 45° angle with the skin. Puncture the needle into skin and inject insulin. Then pull the needle out and apply gentle pressure over the injected site for several seconds. Do not rub the injection site.DOSAGEThe dosage form, the dosage and the administration time of the insulin are different due to the individual differences of each patient. In addition, the dosage is also affected by food, working style and exercising intensity. Therefore, patients should use the insulin under doctor's instruction. The average range of total daily insulin requirement for maintenance therapy in type 1 diabetic patients lies between 0.5 and 1.0 IU/kg. In pre-pubertal children it usually varies from 0.7 to 1.0 IU/kg, whereas in insulin resistant cases, e.g. during puberty or due to obesity, the daily insulin requirement may be substantially higher. Initial dosages for type 2 diabetic patients are often lower, e.g. 0.3 to 0.6 IU/kg/day.ADVERSE EFFECTHypoglycemia is the most common adverse effect during insulin treatment and symptoms of hypoglycemia may occur suddenly. Few cases of the allergic reaction such as red and swollen or itching are reported. It usually disappears in a few days. In some instances, the allergy may be caused by other reasons rather than insulin, such as disinfectant and poor injection technique.CONTRAINDICATIONHypoglycemia or the patients who have allergic reaction to insulin or any of the excipients.PRECAUTIONInadequate dosing or discontinuation especially in type 1 diabetes, may lead to hyperglycemia. Hypoglycemia may occur if the insulin dose is too high in relation to the insulin requirement. Omission of a meal or unplanned, strenuous physical exercise may lead to hypoglycemia.PREGNANCY AND LACTATIONThere are no restrictions on treatment of diabetes with insulin during pregnancy, as insulin does not pass the placental barrier. Insulin treatment of the nursing mother presents no risk to the baby.DRUG INTERACTIONWhen using oral contracep..
Tk.195.00/=
Ansulin 50/50 100IU Inj
Indication: Type 1 and Type 2 Diabetes Mellitus. Dosage & Administration The dosage form, the dosage and the administration time of the insulin are different due to the individual differences of each patient. In addition, the dosage is also affected by food, working style and exercising intensity. Therefore, patients should use the insulin under doctor\'s instruction. The average range of total daily insulin requirement for maintenance therapy in type 1 diabetic patients lies between 0.5 and 1.0 IU/kg. In pre-pubertal children it usually varies from 0.7 to 1.0 IU/kg, whereas in insulin resistant cases, e.g. during puberty or due to obesity, the daily insulin requirement may be substantially higher. Initial dosages for type 2 diabetic patients are often lower, e.g. 0.3 to 0.6 IU/kg/day. PHARMACOLOGY Ansulin® is human insulin made by DNA recombinant technology so it has the same structure and function as natural insulin. The product can regulate the glucose metabolism and stimulate the ingestion and utilization of glucose by liver, muscles, and fat tissue. It can accelerate the transformation from glucose to glycogen stored in muscles and liver and inhibit the gluconeogenesis, thus, to lower the blood glucose. Normally, Ansulin® R takes effect within 30 minutes after injection, reaches its peak within 1-3 hours and lasts about 4-8 hours. On the other hand, Ansulin® N comes into effect slowly after injection, reaches its peak within 6-9 hours & lasts about 24 hours. Ansulin® 30/70 & Ansulin® 50/50 take effect within 30 minutes after injection, reach their peaks within 2-8 hours and last about 24 hours. USAGE 1. Ansulin® should be injected subcutaneously 15 minutes to one hour before meal. The exact time for administration is suggested by doctors with regard to each individual's case. 2. Prepare before use Firstly, clean your hands. Shake or rotate the vial gently to mix the solution uniformly and check if the insulin has the normal appearance. If using a new Ansulin® bottle then flip off the plastic protective cap and wipe the rubber stopper with an alcohol swab. Draw air into your syringe equal to the amount of insulin needed. Puncture the needle into the vial and inject the air. Turn the bottle and syringe upside down. Withdraw correct dose of insulin into the syringe. Before pulling out the needle, check if there are any bubbles remain in the syringe. If so, put the syringe upright and tap the syringe to discharge the air bubbles. 3. Injection Site Choose the area where skin is less tight, such as the upper arm, thigh, buttock and abdomen, etc. To avoid tissue damage, choose a site for each injection that is at least 1 cm from the previous injection site. 4. Injection Method Cleanse the skin with alcohol where the injection is to be made. Put the needle in such a position as to form 45° angle with the skin. Puncture the needle into skin and inject insulin. Then pull the needle out and apply gentle pressure over the injected site for several seconds. Do not rub the injection site. DOSAGE The dosage form, the dosage and the administration time of the insulin are different due to the individual differences of each patient. In addition, the dosage is also affected by food, working style and exercising intensity. Therefore, patients should use the insulin under doctor's instruction. The average range of total daily insulin requirement for maintenance therapy in type 1 diabetic patients lies between 0.5 and 1.0 IU/kg. In pre-pubertal children it usually varies from 0.7 to 1.0 IU/kg, whereas in insulin resistant cases, e.g. during puberty or due to obesity, the daily insulin requirement may be substantially higher. Initial dosages for type 2 diabetic patients are often lower, e.g. 0.3 to 0.6 IU/kg/day. ADVERSE EFFECT Hypoglycemia is the most common adverse effect during insulin treatment and symptoms of hypoglycemia may occur suddenly. Few cases of the allergic reaction such as red and swollen or itching are reported. It usually disappears in a few days. In some instances, the allergy may be caused by other reasons rather than insulin, such as disinfectant and poor injection technique. CONTRAINDICATION Hypoglycemia or the patients who have allergic reaction to insulin or any of the excipients. PRECAUTION Inadequate dosing or discontinuation especially in type 1 diabetes, may lead to hyperglycemia. Hypoglycemia may occur if the insulin dose is too high in relation to the insulin requirement. Omission of a meal or unplanned, strenuous physical exercise may lead to hypoglycemia. PREGNANCY AND LACTATION There are no restrictions on treatment of diabetes with insulin during pregnancy, as ..
Tk.415.00/=
Ansulin N 100 IU
Indication: Type 1 and Type 2 Diabetes Mellitus. Dosage & Administration The dosage form, the dosage and the administration time of the insulin are different due to the individual differences of each patient. In addition, the dosage is also affected by food, working style and exercising intensity. Therefore, patients should use the insulin under doctor\'s instruction. The average range of total daily insulin requirement for maintenance therapy in type 1 diabetic patients lies between 0.5 and 1.0 IU/kg. In pre-pubertal children it usually varies from 0.7 to 1.0 IU/kg, whereas in insulin resistant cases, e.g. during puberty or due to obesity, the daily insulin requirement may be substantially higher. Initial dosages for type 2 diabetic patients are often lower, e.g. 0.3 to 0.6 IU/kg/day. PHARMACOLOGY Ansulin® is human insulin made by DNA recombinant technology so it has the same structure and function as natural insulin. The product can regulate the glucose metabolism and stimulate the ingestion and utilization of glucose by liver, muscles, and fat tissue. It can accelerate the transformation from glucose to glycogen stored in muscles and liver and inhibit the gluconeogenesis, thus, to lower the blood glucose. Normally, Ansulin® R takes effect within 30 minutes after injection, reaches its peak within 1-3 hours and lasts about 4-8 hours. On the other hand, Ansulin® N comes into effect slowly after injection, reaches its peak within 6-9 hours & lasts about 24 hours. Ansulin® 30/70 & Ansulin® 50/50 take effect within 30 minutes after injection, reach their peaks within 2-8 hours and last about 24 hours. USAGE 1. Ansulin® should be injected subcutaneously 15 minutes to one hour before meal. The exact time for administration is suggested by doctors with regard to each individual's case. 2. Prepare before use Firstly, clean your hands. Shake or rotate the vial gently to mix the solution uniformly and check if the insulin has the normal appearance. If using a new Ansulin® bottle then flip off the plastic protective cap and wipe the rubber stopper with an alcohol swab. Draw air into your syringe equal to the amount of insulin needed. Puncture the needle into the vial and inject the air. Turn the bottle and syringe upside down. Withdraw correct dose of insulin into the syringe. Before pulling out the needle, check if there are any bubbles remain in the syringe. If so, put the syringe upright and tap the syringe to discharge the air bubbles. 3. Injection Site Choose the area where skin is less tight, such as the upper arm, thigh, buttock and abdomen, etc. To avoid tissue damage, choose a site for each injection that is at least 1 cm from the previous injection site. 4. Injection Method Cleanse the skin with alcohol where the injection is to be made. Put the needle in such a position as to form 45° angle with the skin. Puncture the needle into skin and inject insulin. Then pull the needle out and apply gentle pressure over the injected site for several seconds. Do not rub the injection site. DOSAGE The dosage form, the dosage and the administration time of the insulin are different due to the individual differences of each patient. In addition, the dosage is also affected by food, working style and exercising intensity. Therefore, patients should use the insulin under doctor's instruction. The average range of total daily insulin requirement for maintenance therapy in type 1 diabetic patients lies between 0.5 and 1.0 IU/kg. In pre-pubertal children it usually varies from 0.7 to 1.0 IU/kg, whereas in insulin resistant cases, e.g. during puberty or due to obesity, the daily insulin requirement may be substantially higher. Initial dosages for type 2 diabetic patients are often lower, e.g. 0.3 to 0.6 IU/kg/day. ADVERSE EFFECT Hypoglycemia is the most common adverse effect during insulin treatment and symptoms of hypoglycemia may occur suddenly. Few cases of the allergic reaction such as red and swollen or itching are reported. It usually disappears in a few days. In some instances, the allergy may be caused by other reasons rather than insulin, such as disinfectant and poor injection technique. CONTRAINDICATION Hypoglycemia or the patients who have allergic reaction to insulin or any of the excipients. PRECAUTION Inadequate dosing or discontinuation especially in type 1 diabetes, may lead to hyperglycemia. Hypoglycemia may occur if the insulin dose is too high in relation to the insulin requirement. Omission of a meal or unplanned, strenuous physical exercise may lead to hypoglycemia. PREGNANCY AND LACTATION There are no restrictions on treatment of diabetes with insulin during pregnancy, as ..
Tk.415.00/=
Ansulin N 40 IU
Indication: Type 1 and Type 2 Diabetes Mellitus. Dosage & Administration The dosage form, the dosage and the administration time of the insulin are different due to the individual differences of each patient. In addition, the dosage is also affected by food, working style and exercising intensity. Therefore, patients should use the insulin under doctor\'s instruction. The average range of total daily insulin requirement for maintenance therapy in type 1 diabetic patients lies between 0.5 and 1.0 IU/kg. In pre-pubertal children it usually varies from 0.7 to 1.0 IU/kg, whereas in insulin resistant cases, e.g. during puberty or due to obesity, the daily insulin requirement may be substantially higher. Initial dosages for type 2 diabetic patients are often lower, e.g. 0.3 to 0.6 IU/kg/day. PHARMACOLOGY Ansulin® is human insulin made by DNA recombinant technology so it has the same structure and function as natural insulin. The product can regulate the glucose metabolism and stimulate the ingestion and utilization of glucose by liver, muscles, and fat tissue. It can accelerate the transformation from glucose to glycogen stored in muscles and liver and inhibit the gluconeogenesis, thus, to lower the blood glucose. Normally, Ansulin® R takes effect within 30 minutes after injection, reaches its peak within 1-3 hours and lasts about 4-8 hours. On the other hand, Ansulin® N comes into effect slowly after injection, reaches its peak within 6-9 hours & lasts about 24 hours. Ansulin® 30/70 & Ansulin® 50/50 take effect within 30 minutes after injection, reach their peaks within 2-8 hours and last about 24 hours. USAGE 1. Ansulin® should be injected subcutaneously 15 minutes to one hour before meal. The exact time for administration is suggested by doctors with regard to each individual's case. 2. Prepare before use Firstly, clean your hands. Shake or rotate the vial gently to mix the solution uniformly and check if the insulin has the normal appearance. If using a new Ansulin® bottle then flip off the plastic protective cap and wipe the rubber stopper with an alcohol swab. Draw air into your syringe equal to the amount of insulin needed. Puncture the needle into the vial and inject the air. Turn the bottle and syringe upside down. Withdraw correct dose of insulin into the syringe. Before pulling out the needle, check if there are any bubbles remain in the syringe. If so, put the syringe upright and tap the syringe to discharge the air bubbles. 3. Injection Site Choose the area where skin is less tight, such as the upper arm, thigh, buttock and abdomen, etc. To avoid tissue damage, choose a site for each injection that is at least 1 cm from the previous injection site. 4. Injection Method Cleanse the skin with alcohol where the injection is to be made. Put the needle in such a position as to form 45° angle with the skin. Puncture the needle into skin and inject insulin. Then pull the needle out and apply gentle pressure over the injected site for several seconds. Do not rub the injection site. DOSAGE The dosage form, the dosage and the administration time of the insulin are different due to the individual differences of each patient. In addition, the dosage is also affected by food, working style and exercising intensity. Therefore, patients should use the insulin under doctor's instruction. The average range of total daily insulin requirement for maintenance therapy in type 1 diabetic patients lies between 0.5 and 1.0 IU/kg. In pre-pubertal children it usually varies from 0.7 to 1.0 IU/kg, whereas in insulin resistant cases, e.g. during puberty or due to obesity, the daily insulin requirement may be substantially higher. Initial dosages for type 2 diabetic patients are often lower, e.g. 0.3 to 0.6 IU/kg/day. ADVERSE EFFECT Hypoglycemia is the most common adverse effect during insulin treatment and symptoms of hypoglycemia may occur suddenly. Few cases of the allergic reaction such as red and swollen or itching are reported. It usually disappears in a few days. In some instances, the allergy may be caused by other reasons rather than insulin, such as disinfectant and poor injection technique. CONTRAINDICATION Hypoglycemia or the patients who have allergic reaction to insulin or any of the excipients. PRECAUTION Inadequate dosing or discontinuation especially in type 1 diabetes, may lead to hyperglycemia. Hypoglycemia may occur if the insulin dose is too high in relation to the insulin requirement. Omission of a meal or unplanned, strenuous physical exercise may lead to hypoglycemia. PREGNANCY AND LACTATION There are no restrictions on treatment of diabetes with insulin during pregnancy, as ..
Tk.195.00/=
Ansulin R 40 IU
Indication: Type 1 and Type 2 Diabetes Mellitus. Dosage & Administration The dosage form, the dosage and the administration time of the insulin are different due to the individual differences of each patient. In addition, the dosage is also affected by food, working style and exercising intensity. Therefore, patients should use the insulin under doctor\'s instruction. The average range of total daily insulin requirement for maintenance therapy in type 1 diabetic patients lies between 0.5 and 1.0 IU/kg. In pre-pubertal children it usually varies from 0.7 to 1.0 IU/kg, whereas in insulin resistant cases, e.g. during puberty or due to obesity, the daily insulin requirement may be substantially higher. Initial dosages for type 2 diabetic patients are often lower, e.g. 0.3 to 0.6 IU/kg/day. PHARMACOLOGY Ansulin® is human insulin made by DNA recombinant technology so it has the same structure and function as natural insulin. The product can regulate the glucose metabolism and stimulate the ingestion and utilization of glucose by liver, muscles, and fat tissue. It can accelerate the transformation from glucose to glycogen stored in muscles and liver and inhibit the gluconeogenesis, thus, to lower the blood glucose. Normally, Ansulin® R takes effect within 30 minutes after injection, reaches its peak within 1-3 hours and lasts about 4-8 hours. On the other hand, Ansulin® N comes into effect slowly after injection, reaches its peak within 6-9 hours & lasts about 24 hours. Ansulin® 30/70 & Ansulin® 50/50 take effect within 30 minutes after injection, reach their peaks within 2-8 hours and last about 24 hours. USAGE 1. Ansulin® should be injected subcutaneously 15 minutes to one hour before meal. The exact time for administration is suggested by doctors with regard to each individual's case. 2. Prepare before use Firstly, clean your hands. Shake or rotate the vial gently to mix the solution uniformly and check if the insulin has the normal appearance. If using a new Ansulin® bottle then flip off the plastic protective cap and wipe the rubber stopper with an alcohol swab. Draw air into your syringe equal to the amount of insulin needed. Puncture the needle into the vial and inject the air. Turn the bottle and syringe upside down. Withdraw correct dose of insulin into the syringe. Before pulling out the needle, check if there are any bubbles remain in the syringe. If so, put the syringe upright and tap the syringe to discharge the air bubbles. 3. Injection Site Choose the area where skin is less tight, such as the upper arm, thigh, buttock and abdomen, etc. To avoid tissue damage, choose a site for each injection that is at least 1 cm from the previous injection site. 4. Injection Method Cleanse the skin with alcohol where the injection is to be made. Put the needle in such a position as to form 45° angle with the skin. Puncture the needle into skin and inject insulin. Then pull the needle out and apply gentle pressure over the injected site for several seconds. Do not rub the injection site. DOSAGE The dosage form, the dosage and the administration time of the insulin are different due to the individual differences of each patient. In addition, the dosage is also affected by food, working style and exercising intensity. Therefore, patients should use the insulin under doctor's instruction. The average range of total daily insulin requirement for maintenance therapy in type 1 diabetic patients lies between 0.5 and 1.0 IU/kg. In pre-pubertal children it usually varies from 0.7 to 1.0 IU/kg, whereas in insulin resistant cases, e.g. during puberty or due to obesity, the daily insulin requirement may be substantially higher. Initial dosages for type 2 diabetic patients are often lower, e.g. 0.3 to 0.6 IU/kg/day. ADVERSE EFFECT Hypoglycemia is the most common adverse effect during insulin treatment and symptoms of hypoglycemia may occur suddenly. Few cases of the allergic reaction such as red and swollen or itching are reported. It usually disappears in a few days. In some instances, the allergy may be caused by other reasons rather than insulin, such as disinfectant and poor injection technique. CONTRAINDICATION Hypoglycemia or the patients who have allergic reaction to insulin or any of the excipients. PRECAUTION Inadequate dosing or discontinuation especially in type 1 diabetes, may lead to hyperglycemia. Hypoglycemia may occur if the insulin dose is too high in relation to the insulin requirement. Omission of a meal or unplanned, strenuous physical exercise may lead to hypoglycemia. PREGNANCY AND LACTATION There are no restrictions on treatment of diabetes with insulin during pregnancy, as insulin does not pass the placental barrier. Insulin treatment of the nursing moth..
Tk.195.00/=
Antazol 0.1% Nasal Drop
Antazol 0.1% N-DropsIndication:Nasal congestion, seasonal & perennial allergic rhinitis, sinusitis.Dosage & Administration:Adults: 2 or 3 drops adult formula (0.1%) 2-3 times daily. Children under 12 years: 1 or 2 drops children's formula (0.05%) in each nostril 1-2 times daily. Not to be used in infants less than 3 months.Preparation:Antazol® 0.05% Nasal Drops (for children): 15ml in plastic droppered bottle.Antazol® 0.1% Nasal Drops (for adults): 15ml in plastic droppered bottle...
Tk.20.00/=
Anzitor 10 mg Tablet
Indication: Anzitor ® is indicated as an adjunct to diet for reduction of elevated total cholesterol, LDL-cholesterol, apolipoprotein B, and triglycerides in patients with- 1. Primary hypercholesterolemia (heterozygous familial and non-familial hypercholesterolemia and mixed dyslipidemia (Fredrickson types IIa and IIb)) 2. Elevated serum TG levels (Fredrickson type IV) 3. Primary dysbetalipoproteinemia (Fredrickson type III) who do not respond adequately to diet. 4. Homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatments (eg, LDL apheresis) or if such treatments are unavailable.Preparation: Anzitor ® 10: Each box contains 50 film coated tablets in Alu-Alu blister pack. Anzitor ® 20: Each box contains 30 film coated tablets in Alu-Alu blister pack. Anzitor ® 40: Each box contains 10 film coated tablets in Alu-Alu blister pack. ..
Tk.12.00/=
Anzitor 20 mg Tablet
Indication: Anzitor ® is indicated as an adjunct to diet for reduction of elevated total cholesterol, LDL-cholesterol, apolipoprotein B, and triglycerides in patients with- 1. Primary hypercholesterolemia (heterozygous familial and non-familial hypercholesterolemia and mixed dyslipidemia (Fredrickson types IIa and IIb)) 2. Elevated serum TG levels (Fredrickson type IV) 3. Primary dysbetalipoproteinemia (Fredrickson type III) who do not respond adequately to diet. 4. Homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatments (eg, LDL apheresis) or if such treatments are unavailable.Preparation: Anzitor ® 10: Each box contains 50 film coated tablets in Alu-Alu blister pack. Anzitor ® 20: Each box contains 30 film coated tablets in Alu-Alu blister pack. Anzitor ® 40: Each box contains 10 film coated tablets in Alu-Alu blister pack. ..
Tk.20.00/=
Anzitor 40 mg Tablet
Indication: Anzitor ® is indicated as an adjunct to diet for reduction of elevated total cholesterol, LDL-cholesterol, apolipoprotein B, and triglycerides in patients with- 1. Primary hypercholesterolemia (heterozygous familial and non-familial hypercholesterolemia and mixed dyslipidemia (Fredrickson types IIa and IIb)) 2. Elevated serum TG levels (Fredrickson type IV) 3. Primary dysbetalipoproteinemia (Fredrickson type III) who do not respond adequately to diet. 4. Homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatments (eg, LDL apheresis) or if such treatments are unavailable.Preparation: Anzitor ® 10: Each box contains 50 film coated tablets in Alu-Alu blister pack. Anzitor ® 20: Each box contains 30 film coated tablets in Alu-Alu blister pack. Anzitor ® 40: Each box contains 10 film coated tablets in Alu-Alu blister pack. ..
Tk.28.00/=
Ariprex 10 mg Tablet
Indication: AriprexTM is indicated for schizophrenia, bipolar disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, agitation associated with schizophrenia or bipolar mania.Dosage & Administration:Indications Initial Dose Recommended Dose Maximum Dose Schizophrenia – adults 10-15 mg/day 10-15 mg/day 30 mg/day Schizophrenia – adolescents (ages 13-17 years) 2 mg/day 10 mg/day 30 mg/day Bipolar mania – adults: monotherapy 15 mg/day 15 mg/day 30 mg/day Bipolar mania – adults: adjunct to lithium or valproate 10-15 mg/day 15 mg/day 30 mg/day Bipolar mania – pediatric patients (ages 10-17 years): monotherapy or as an adjunct to lithium or valproate 2 mg/day 10 mg/day 30 mg/day As an adjunct to antidepressants for the treatment of major depressive disorder– adults 2-5 mg/day 5-10 mg/day 15 mg/day Irritability associated with autistic disorder-pediatric patients (ages 6-17 years) 2 mg/day 5-10 mg/day 15 mg/day • Oral formulations: Administer once daily without regard to meals Preparation: AriprexTM 2 Tablet: Box containing 30 tablets in blister pack AriprexTM 10 Tablet: Box containing 30 tablets in blister pack AriprexTM 15 Tablet: Box containing 30 tablets in blister pack AriprexTMIndications Initial Dose Recommended Dose Maximum Dose Schizophrenia – adults 10-15 mg/day 10-15 mg/day 30 mg/day Schizophrenia – adolescents (ages 13-17 years) 2 mg/day 10 mg/day 30 mg/day Bipolar mania – adults: monotherapy 15 mg/day 15 mg/day 30 mg/day Bipolar mania – adults: adjunct to lithium or valproate 10-15 mg/day 15 mg/day 30 mg/day Bipolar mania – pediatric patients (ages 10-17 years): monotherapy or as an adjunct to lithium or valproate 2 mg/day 10 mg/day 30 mg/day As an adjunct to antidepressants for the treatment of major depressive disorder– adults 2-5 mg/day 5-10 mg/day 15 mg/day Irritability associated with autistic disorder-pediatric patients (ages 6-17 years) 2 mg/day 5-10 mg/day 15 mg/day • Oral formulations: Administer once daily without regard to meals Preparation: AriprexTM 2 Tablet: Box containing 30 tablets in blister pack AriprexTM 10 Tablet: Box containing 30 tablets in blister pack AriprexTM 15 Tablet: Box containing 30 tablets in blister pack AriprexTM..
Tk.5.00/=
Ariprex 15 Tab
Indication: AriprexTM is indicated for schizophrenia, bipolar disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, agitation associated with schizophrenia or bipolar mania.Dosage & Administration:Indications Initial Dose Recommended Dose Maximum Dose Schizophrenia – adults 10-15 mg/day 10-15 mg/day 30 mg/day Schizophrenia – adolescents (ages 13-17 years) 2 mg/day 10 mg/day 30 mg/day Bipolar mania – adults: monotherapy 15 mg/day 15 mg/day 30 mg/day Bipolar mania – adults: adjunct to lithium or valproate 10-15 mg/day 15 mg/day 30 mg/day Bipolar mania – pediatric patients (ages 10-17 years): monotherapy or as an adjunct to lithium or valproate 2 mg/day 10 mg/day 30 mg/day As an adjunct to antidepressants for the treatment of major depressive disorder– adults 2-5 mg/day 5-10 mg/day 15 mg/day Irritability associated with autistic disorder-pediatric patients (ages 6-17 years) 2 mg/day 5-10 mg/day 15 mg/day • Oral formulations: Administer once daily without regard to meals Preparation: AriprexTM 2 Tablet: Box containing 30 tablets in blister pack AriprexTM 10 Tablet: Box containing 30 tablets in blister pack AriprexTM 15 Tablet: Box containing 30 tablets in blister pack AriprexTM Oral Solution: Eack PET bottle contains 50 ml oral solution with measuring cup & dropper ..
Tk.7.00/=
Ariprex 50ML Oral Solution
Indication: AriprexTM is indicated for schizophrenia, bipolar disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, agitation associated with schizophrenia or bipolar mania.Dosage & Administration: Indications Initial Dose Recommended Dose Maximum Dose Schizophrenia – adults 10-15 mg/day 10-15 mg/day 30 mg/day Schizophrenia – adolescents (ages 13-17 years) 2 mg/day 10 mg/day 30 mg/day Bipolar mania – adults: monotherapy 15 mg/day 15 mg/day 30 mg/day Bipolar mania – adults: adjunct to lithium or valproate 10-15 mg/day 15 mg/day 30 mg/day Bipolar mania – pediatric patients (ages 10-17 years): monotherapy or as an adjunct to lithium or valproate 2 mg/day 10 mg/day 30 mg/day As an adjunct to antidepressants for the treatment of major depressive disorder– adults 2-5 mg/day 5-10 mg/day 15 mg/day Irritability associated with autistic disorder-pediatric patients (ages 6-17 years) 2 mg/day 5-10 mg/day 15 mg/day • Oral formulations: Administer once daily without regard to meals Preparation: AriprexTM 2 Tablet: Box containing 30 tablets in blister pack AriprexTM 10 Tablet: Box containing 30 tablets in blister pack AriprexTM 15 Tablet: Box containing 30 tablets in blister pack AriprexTM Oral Solution: Eack PET bottle contains 50 ml oral solution with measuring cup & dropper ..
Tk.75.00/=
Asynta Tab
Indication: Treatment of symptoms of gastro-oesophageal reflux such as acid regurgitation, heartburn and indigestion (related to reflux), for example, following meals, or during pregnancy, or in patients with symptoms related to reflux oesophagitis.Dosage & Administration:AsyntaTM Tablet: Daily 4 times, after meals and at bedtime Adult and children over 12 years: 1-2 tablets to be chewed after meals and at bedtime. Children 6- 12 years: 1 tablet to be chewed after meals and at bedtime. AsyntaTM Suspension: Daily 4 times, after meals and at bedtime Adult and children over 12 years: 1-2 teaspoonfuls (5-10 ml) Suspension Children 2 - 12 years: 1-2 teaspoonfuls (2.5-5 ml) Suspension Preparation: AsyntaTM Tablet: Each box contains 50 Chewable Tablets in blister pack. AsyntaTMSuspension: Each PET bottle contains 200 ml of suspension...
Tk.3.51/=
B-50 Forte Cap
Indication: Glossitis, Stomatitis, Cheilosis, Beriberi, Polyneuritis etc.Dosage & Administration:Capsule: 1-2 capsule 3 times daily or as directed by the physician.Syrup: 2-3 teaspoonful’s daily. Injection: 2 ml daily IV or IM.Preparation: B-50® Forte capsule: Box containing 25x10 capsules in strip pack.B-50® Forte syrup: Bottle containing 200 ml syrup. B-50® Forte injection: Box containing 2x5 ampoules in blister pac..
Tk.1.25/=
-140x140.jpg "Beclomin 250 HFA")
Beclomin 250 HFA
Indication: Beclometasone 100 & 250 HFA Inhaler is indicated in the prophylactic management of mild, moderate, or severe asthma in adults or children. Beclometasone dipropionate given by inhalation offers preventative treatment for asthma. It provides effective anti-inflammatory action in the lungs with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically. Mild asthma : Patients requiring symptomatic bronchodilator asthma medication on a regular basis. Moderate asthma: Patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone. Severe asthma : Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms. Many patients who are dependent on systemic corticosteroids for adequate control of symptoms may be able to reduce significantly, or eliminate, their requirement for oral corticosteroids when they are transferred to high dose inhaled beclometasone dipropionate...
Tk.320.96/=
Becospary Nasal Spray
Becospary N-SprayIndication:Seasonal & perennial allergic rhinitis including hay fever & non-allergic (vasomotor) rhinitis.Dosage & Administration:Adults : 02 sprays in each nostril twice daily.Children (6 to 12 years of age): 01 spray in each nostril twice daily.Children under 6 years of age: Not recommended.Preparation:Becospray® : Each bottle contains Beclomethasone dipropionate aqueous suspension adequate for 200 metered doses...
Tk.146.01/=
Benzapen 12 Lac
Indication: Penicillin-sensitive infections, acute otitis media, syphilis, diphtheria carriers and prophylaxis against rheumatic fever and streptococcal infections.Dosage & Administration:0.3 to 1.2 million units up to 2.4 million units as a single dose repeated every five to seven days.Preparation: Benzapen® injection: Box containing 5 blister pack, each containing one vial and one 5 ml ampoule of Water for Injection...
Tk.28.04/=
Bicozin 200ml Syrup
Indication: Treatment and prevention of B-vitamins and Zinc deficiencies.Dosage & Administration:Bicozin Syrup : Adults : 10 ml (2 teaspoonfuls) 2 to 3 times daily, Children : 10 ml (2 teaspoonfuls) 1 to 3 times daily, Infants: 5 ml (1 teaspoonful) 1 to 2 times daily. Bicozin Tablet : Adults & Children over 30 kg : 1 to 2 tablets 2 to 3 times daily.Preparation: Thiamine Hydrochloride 5 mg, Riboflavin 2 mg, Pyridoxine Hydrochloride 2 mg, Nicotinamide 20 mg and elemental Zinc 10 mg/5 ml Syrup. Thiamine Mononitrate 5 mg, Riboflavin 2 mg, Pyridoxine Hydrochloride 2 mg, Nicotinamide 20 mg & elemental Zinc 10 mg/Tablet...
Tk.94.99/=
Bicozin Tablet 30's, 1 Pot
Indication: Treatment and prevention of B-vitamins and Zinc deficiencies.Dosage & Administration:Bicozin Syrup : Adults : 10 ml (2 teaspoonfuls) 2 to 3 times daily, Children : 10 ml (2 teaspoonfuls) 1 to 3 times daily, Infants: 5 ml (1 teaspoonful) 1 to 2 times daily. Bicozin Tablet : Adults & Children over 30 kg : 1 to 2 tablets 2 to 3 times daily.Preparation: Thiamine Hydrochloride 5 mg, Riboflavin 2 mg, Pyridoxine Hydrochloride 2 mg, Nicotinamide 20 mg and elemental Zinc 10 mg/5 ml Syrup. Thiamine Mononitrate 5 mg, Riboflavin 2 mg, Pyridoxine Hydrochloride 2 mg, Nicotinamide 20 mg & elemental Zinc 10 mg/Tablet...
Tk.90.00/=
Bicozin-I 100ml Syrup
Indication: Bicozin-I® syrup is indicated for the treatment and prevention of Iron, B-vitamins and Zinc deficiencies.Dosage & Administration:Adults: 5 ml-10 ml (1-2 teaspoonful) 3 times daily or as recommended by the physician. Children: 5 ml (1 teaspoonful) 3 times daily or as recommended by the physician. Infants: 0.33 ml/kg body weight daily or as recommended by the physician.Preparation: Bicozin-I® 100 ml syrup: Each pack has a PET bottle containing 100 ml syrup and a measuring spoon...
Tk.50.35/=